|
Merial is the world's
leading and most successful animal health company producing a wide
range of pharmaceuticals and vaccines to keep livestock and pets
healthy and productive.
An innovation-driven leader, Merial has the
largest research & development investment in the animal health
industry with seventeen research and development centres around the
world. Merial is committed to developing pharmaceuticals and vaccines
with the highest level of quality, safety and efficacy through an
extensive network of sixteen manufacturing sites globally.
Headquartered in the UK, with operations based in
the US, France, Latin America and Asia, Merial employs approximately
6,500 people, operates in more than 150 countries and generates sales
in excess of $1.7 billion Euros.
Manufacturing:
Merial's worldwide network of manufacturing
sites provides the global market with competitive solutions.
Proximity to customers ensures a steady supply of
safe, high-quality products whenever and wherever needed. Our strong
production capability enables us to supply millions of doses of
vaccines in a matter of days when epidemics strike - and to keep
veterinarians, food animal producers and farmers everywhere supplied
with the products they need.
Merial around the world:
Merial meets the needs of global markets
through an extensive network of over 20 manufacturing sites worldwide,
placing our sales and distribution capabilities in close proximity to
all of our customers.
Innovation:
One of the largest Research & Development investment in the animal
health industry, and a worldwide network of laboratories, enable
Merial to achieve continuous innovation in animal healthcare.
Highly-focused R&D personnel and
programmes enable us to anticipate and respond to the needs of a
rapidly-changing animal health industry.
Merial's R&D
benefits from full access to the extensive research resources of our
parent companies (Merck & Co. Inc, and Aventis S.A.)- two of the
world's leading life science companies.
Pipeline:
One of Merial's most
powerful resources is its rich and exciting pipeline on which the
company's strength and future growth are being built.
Merial's research
philosophy emphasises the development of new products to enhance the
health and performance of all livestock and companion animal species
and to protect against parasitic, enteric and respiratory diseases in
bovine, porcine and companion animal species.
Research programmes
specifically dedicated to avian species are also in development.
Epidemiological
Surveillance:
Merial is commited to
effective epidemiological surveillance. By helping to develop and
enforce international policies and regulations regarding animal health
and welfare, Merial actively participates in the fight against major
epidemics throughout the world. When new strains of viruses appear,
Merial research teams react rapidly and effectively, developing the
powerful new vaccines needed to fight them.
Merial is the
worldwide leader in animal health. We take our responsibilities
seriously recognizing that the invention of effective animal health
products has not only made the prevention and care of animal disease
possible, but also protects the health and well-being of man.
|
